Conceptio
›
diphtheria
Topic
diphtheria
Knowledge-graph topic
· documents ABOUT diphtheria across the archive
113
Documents about diphtheria
Documents about diphtheria
Diphtheria Vaccination Coverage and Correlation With Multidimensional Poverty Among Children in Nigeria
#5228
Europe PMC
Safety and monitoring in patients receiving diphtheria antitoxin, 2 February 2024
#362963
WHO IRIS
Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine
#356518
ClinicalTrials.gov
Clinical Features of Children with Diphtheria on Soetomo Hospital
#1004946
Jurnal Ners
US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease
#417583
ClinicalTrials.gov
Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults
#874216
ClinicalTrials.gov
Epidemiology of diphtheria
#10874
Crossref
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
#272433
ClinicalTrials.gov
Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine
#864062
ClinicalTrials.gov
Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
#911927
ClinicalTrials.gov
The epidemiology of diphtheria
#10893
Crossref
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
#268084
ClinicalTrials.gov
Antitoxina diftérica, 2 de febrero de 2024
#343061
WHO IRIS
Post Market Surveillance for Infanrix™
#424229
ClinicalTrials.gov
A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)
#180199
ClinicalTrials.gov
Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea
#343702
ClinicalTrials.gov
Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older
#854080
ClinicalTrials.gov
Duration of Protection: GSK DTaP Vaccines
#831420
ClinicalTrials.gov
Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®
#181607
ClinicalTrials.gov
Infection prevention and control measures when caring for patients with suspected or confirmed respiratory diphtheria: a summary
#349384
WHO IRIS
Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m
#847212
ClinicalTrials.gov
Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
#249680
ClinicalTrials.gov
Confirmatory Study of BK1310 in Healthy Infants
#906201
ClinicalTrials.gov
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years
#373668
ClinicalTrials.gov
Seroprevalence of diphtheria, tetanus, pertussis among healthcare workers (HCWs) - A cross-sectional study at the National Centre for Infectious Diseases and Tan Tock Seng Hospital, Singapore
#5097
Europe PMC
Seguridad y vigilancia de los pacientes que reciben la antitoxina diftérica, 2 de febrero de 2024
#343062
WHO IRIS
Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children
#210589
ClinicalTrials.gov
Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)
#148573
ClinicalTrials.gov
Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers
#844616
ClinicalTrials.gov
Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine
#353342
ClinicalTrials.gov
Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors
#245573
ClinicalTrials.gov
Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines
#253069
ClinicalTrials.gov
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults
#407775
ClinicalTrials.gov
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine
#154732
ClinicalTrials.gov
Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine
#208259
ClinicalTrials.gov
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
#373652
ClinicalTrials.gov
Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children
#683129
ClinicalTrials.gov
Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine
#121425
ClinicalTrials.gov
Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants
#125922
ClinicalTrials.gov
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine
#143657
ClinicalTrials.gov
Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants
#261353
ClinicalTrials.gov
Evaluation of an Infant Immunization Encouragement Program in Nigeria
#287374
ClinicalTrials.gov
Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers
#353334
ClinicalTrials.gov
Factors associated with outbreak of diphtheria in Kafanchan, Kaduna State, Nigeria: July-October 2023.
#378578
NCBI PubMed Central
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
#383616
ClinicalTrials.gov
Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)
#411262
ClinicalTrials.gov
Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years
#448211
ClinicalTrials.gov
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
#917309
ClinicalTrials.gov
Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine
#160189
ClinicalTrials.gov
Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine
#268069
ClinicalTrials.gov
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.